Sodium Nitroprusside (Akorn, Inc.)
Welcome to the PulseAid listing for the Sodium Nitroprusside drug offered from Akorn, Inc.. This Vasodilation [PE],Vasodilator [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Akorn, Inc. |
| NON-PROPRIETARY NAME: | Sodium Nitroprusside |
| SUBSTANCE NAME: | SODIUM NITROPRUSSIDE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Vasodilation [PE],Vasodilator [EPC] |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTION, SOLUTION, CONCENTRATE |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2017-05-04 |
| END MARKETING DATE: | 0000-00-00 |
Sodium Nitroprusside HUMAN PRESCRIPTION DRUG Details:
| Item Description | Sodium Nitroprusside from Akorn, Inc. |
| LABELER NAME: | Akorn, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 50(mg/2mL) |
| START MARKETING DATE: | 2017-05-04 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 17478-014_03519ae4-0c72-4acf-a759-f992f7b10273 |
| PRODUCT NDC: | 17478-014 |
| APPLICATION NUMBER: | ANDA208635 |
Other SODIUM NITROPRUSSIDE Pharmaceutical Manufacturers / Labelers:
